Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos

MILWAUKEE, Dec. 14, 2023 /PRNewswire/ — Ademi LLP is investigating Rain (NASDAQ: RAIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Pathos. Click here to learn how to join the https://www.ademilaw.com/case/rain-oncology-inc or call Guri…